IMNM - SEC Form 4 insider transactions

Director Barchas Isaac sold $2,198,910 worth of shares (83,464 units at $26.35) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 92,211 units (SEC Form 4)

Director Barchas Isaac sold $940,453 worth of shares (36,088 units at $26.06) as part of a pre-agreed trading plan (SEC Form 4)

CHIEF BUSINESS OFFICER Horn Kinney exercised 90,616 shares at a strike of $11.89 and sold $2,273,555 worth of shares (90,616 units at $25.09) as part of a pre-agreed trading plan (SEC Form 4)

Chief Scientific Officer Higgins Jack was granted 38,250 shares, increasing direct ownership by 174% to 60,250 units (SEC Form 4)

Chief Technical Officer Tsai Philip was granted 38,250 shares, increasing direct ownership by 88% to 81,550 units (SEC Form 4)

CHIEF LEGAL OFFICER & GC Stoneman Sandra G. was granted 38,250 shares, increasing direct ownership by 689% to 43,805 units (SEC Form 4)

CHIEF BUSINESS OFFICER Horn Kinney was granted 31,250 shares (SEC Form 4)

Chief Financial Officer Rosett Max was granted 47,250 shares, increasing direct ownership by 87% to 101,287 units (SEC Form 4)

President and CEO Siegall Clay B was granted 180,000 shares, increasing direct ownership by 26% to 870,704 units (SEC Form 4)

Chief Medical Officer Lechleider Robert was granted 54,000 shares, increasing direct ownership by 342% to 69,805 units (SEC Form 4)

CHIEF BUSINESS OFFICER Horn Kinney exercised 1,092 shares at a strike of $12.92 and sold $27,300 worth of shares (1,092 units at $25.00) as part of a pre-agreed trading plan (SEC Form 4)

Director Barchas Isaac sold $2,412,522 worth of shares (100,000 units at $24.13) as part of a pre-agreed trading plan (SEC Form 4)

Chief Medical Officer Lechleider Robert exercised 55,000 shares at a strike of $8.73 and sold $1,244,331 worth of shares (55,000 units at $22.62) as part of a pre-agreed trading plan (SEC Form 4)

Director Barchas Isaac sold $4,393,024 worth of shares (201,050 units at $21.85) as part of a pre-agreed trading plan (SEC Form 4)

Chief Medical Officer Lechleider Robert exercised 55,000 shares at a strike of $8.73 and sold $1,091,662 worth of shares (55,000 units at $19.85) as part of a pre-agreed trading plan (SEC Form 4)

Chief Financial Officer Rosett Max sold $1,093,800 worth of shares (60,000 units at $18.23) as part of a pre-agreed trading plan and exercised 60,000 shares at a strike of $1.05 (SEC Form 4)

SEC Form 4 filed by Director Swain Sandra M

SEC Form 4 filed by Director Wagenheim Philip

SEC Form 4 filed by Director Bienaime Jean Jacques

SEC Form 4 filed by Director Boylan James P

SEC Form 4 filed by Director Barchas Isaac

SEC Form 4 filed by Director Schafer Carol

SEC Form 4 filed by Higgins Jack

SEC Form 4 filed by Rosett Max

SEC Form 4 filed by Higgins Jack

SEC Form 4 filed by Siegall Clay B

SEC Form 4 filed by Wagenheim Philip

Director Barchas Isaac sold $8,330,080 worth of shares (383,200 units at $21.74) (SEC Form 4)

Chief Scientific Officer Higgins Jack gifted 3,000 shares and received a gift of 3,000 shares, decreasing direct ownership by 7% to 37,729 units (SEC Form 4)

Chief Scientific Officer Higgins Jack exercised 22,000 shares at a strike of $1.35, increasing direct ownership by 117% to 40,729 units (SEC Form 4)

SEC Form 4 filed by Chief Technical Officer Tsai Philip

SEC Form 4 filed by Chief Financial Officer Rosett Max

SEC Form 4 filed by Chief Medical Officer Lechleider Robert

SEC Form 4 filed by CHIEF BUSINESS OFFICER Horn Kinney

SEC Form 4 filed by Chief Scientific Officer Higgins Jack

SEC Form 4 filed by President and CEO Siegall Clay B

SEC Form 4 filed by CHIEF LEGAL OFFICER & GC Stoneman Sandra G.

SEC Form 4 filed by Director Boylan James P

SEC Form 4 filed by Director Schafer Carol

SEC Form 4 filed by Director Wagenheim Philip

SEC Form 4 filed by Director Barchas Isaac

SEC Form 4 filed by Director Bienaime Jean Jacques

SEC Form 4 filed by Director Swain Sandra M

Chief Scientific Officer Higgins Jack exercised 5,200 shares at a strike of $1.35, increasing direct ownership by 38% to 18,729 units (SEC Form 4)

Chief Financial Officer Rosett Max exercised 42,000 shares at a strike of $1.05 and sold $230,224 worth of shares (14,380 units at $16.01), increasing direct ownership by 139% to 47,476 units (SEC Form 4)

Chief Scientific Officer Higgins Jack gifted 2,471 shares, exercised 19,524 shares at a strike of $1.35 and sold $49,072 worth of shares (3,524 units at $13.93) (SEC Form 4)

SEC Form 4 filed by President and CEO Siegall Clay B

SEC Form 4 filed by CHIEF LEGAL OFFICER & GC Stoneman Sandra G.

SEC Form 4 filed by CHIEF BUSINESS OFFICER Horn Kinney

SEC Form 4 filed by Chief Strategy Officer Turner Bruce

SEC Form 4 filed by EVP, Operations & CFO Rosett Max

SEC Form 4 filed by Chief Medical Officer Lechleider Robert

SEC Form 4 filed by Chief Scientific Officer Higgins Jack

SEC Form 4 filed by Chief Technology Officer Tsai Philip

SEC Form 4 filed by Director Boylan James P

SEC Form 4 filed by Director Schafer Carol

SEC Form 4 filed by Director Swain Sandra M

SEC Form 4 filed by Director Wagenheim Philip

SEC Form 4 filed by Director Bienaime Jean Jacques

SEC Form 4 filed by Director Barchas Isaac